Topics

Pediatric-type diffuse high-grade gliomas | Treatment | Immunotherapy | Natural killer cell therapy

Home > Publications > Topics > Pediatric-type diffuse high-grade gliomas > Treatment > Immunotherapy > Natural killer cell therapy

Mahdizadeh H, Izadpanah A, Nouri Y, Shams P, Daneshjou D, Ahari AA, Tabibkhooei A, Haghighatkhah H, Vosough M, Faranoush P, Azimi M, Yousefi S, Barzegari A, Khosravani A, Asl NS, Faranoush M, Ebrahimi M.
The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors.
BMC Cancer. 2025 May 27;25(1):952. doi: 10.1186/s12885-025-14314-6. PMID: 40426086. Interventional study. ˍ